Prs57 - Economic Evaluation of Single Inhaler Triple Therapy for Patients With Chronic Obstructive Pulmonary Disease (Copd) Using the Galaxy Model

Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.2451
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Prs39 - Cost-Effectiveness of a New Single Inhaler Triple Therapy (Sitt) Versus Multiple Inhaler Triple Therapies (Mitt) to Treat Chronic Obstructive Pulmonary Disease (Copd) in Canada

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

P272 Improvements in Exacerbation Rates With Single Inhaler Triple Therapy Versus Dual Ics/Laba Therapy in Patients With Advanced Chronic Obstructive Pulmonary Disease (Copd): Subgroup Analyses of the Phase Iii Fulfil Study

2017English

P272 Improvements in Exacerbation Rates With Single Inhaler Triple Therapy Versus Dual Ics/Laba Therapy in Patients With Advanced Chronic Obstructive Pulmonary Disease (Copd): Subgroup Analyses of the Phase Iii Fulfil Study

2017English

Evaluation of the Economic and Social Burden of Chronic Obstructive Pulmonary Disease (COPD)

Biotechnology and Biotechnological Equipment
Biotechnology
2017English

Screening COPD (Chronic Obstructive Pulmonary Disease) Patients for Lung Cancer

International Journal of Medical Research Professionals
2016English

Double or Triple Therapy in Chronic Obstructive Pulmonary Disease

Barcelona Respiratory Network
2018English

Evaluation of Risk Factors Causing Osteoporosis in Chronic Obstructive Pulmonary Disease (COPD) Patients.

2019English

Prs21 - Economic Impact of Delaying Initiation With Multiple Inhaler Maintenance Triple Therapy Treatment in Spanish Copd Patients

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Pain in People With Chronic Obstructive Pulmonary Disease (COPD)

Respiratory Medicine
PulmonaryRespiratory Medicine
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy